Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases
European Heart Journal - Cardiovascular Pharmacotherapy · 2025
DOI: 10.1093/ehjcvp/pvae059 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, 2025. Verfasst von Burkhard Weisser und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Sports Science, Christian-Albrechts-University of Kiel, Kiel 24098, Germany. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Drug Costs, Cardiovascular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Aims
Our study aimed to assess whether a single pill concept (SPC) is superior to a multi-pill concept (MPC) in reducing cardiovascular (CV) events, all-cause death, and costs in CV patients. Method and results Anonymized medical claims data covering 2012–2018, including patients with hypertension, dyslipidaemia, and CV diseases who started a drug therapy either as SPC or identical MPC were analysed after 1:1-propensity score matching. Hospitalizations with predefined CV events, all-cause mortality, and costs were studied in 25 311 patients with SPC and 25 311 patients with MPC using incidence rate ratios (IRRs) and non-parametric tests for continuous variables. IRRs were significantly lower for SPC: stroke (IRR = 0.77; 95% CI 0.67–0.88; P < 0.001), transitory ischaemic attack (IRR = 0.61; 95% CI 0.48–0.78; P < 0.001), myocardial infarction (IRR = 0.76; 95% CI 0.63–0.90; P = 0.0016), coronary artery disease (IRR = 0.66; 95% CI 0.57–0.77; P < 0.001), heart failure (IRR = 0.59; 95% CI 0.54–0.64; P < 0.001), acute renal failure (IRR = 0.54; 95% CI 0.56–0.64; P < 0.001), all cause hospitalization (IRR = 0.72; 95% CI 0.71–0.74; P < 0.001), CV hospitalization (IRR = 0.63; 95% CI 0.57–0.69; P < 0.001), and all-cause mortality (IRR = 0.62; 95% CI 0.57–0.68; P < 0.001). Mean time to first events and time to death were also in favour of SPC. Mean total costs were 4708€ for SPC vs. 5.669€ for MPC, respectively (mean ratio 0.830, P < 0.001).
Conclusion
SPC is associated with lower incidence rates of CV events, time to CV events, and all-cause death, and is superior regarding pharmacoeconomic parameters and should therefore become standard of care to improve outcomes and reduce healthcare costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Sports Science, Christian-Albrechts-University of Kiel, Kiel 24098, Germany.
- Cardiology Pasing, Munich, Germany.
- Faculty of Medicine, University of the Saarland, Homburg, Saar, Germany.
- Institute of Cardiology and Sports Medicine, German Sport University, Cologne 50933, Germany.
- Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University Erlangen Nürnberg, Erlangen 91054, Germany.
- Department of Internal Medicine, Herz-Jesu-Hospital, Münster 48149, Germany.
ORCID-Profile: Roland E Schmieder, Olaf Randerath
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Weisser, B., Wassmann, S., Predel, H. G., Schmieder, R. E., Gillessen, A., Wilke, T., Blettenberg, J., Randerath, O., Mevius, A., & Böhm, M. (2025). Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae059
Vancouver
Weisser B, Wassmann S, Predel HG, Schmieder RE, Gillessen A, Wilke T, et al. Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases. European Heart Journal - Cardiovascular Pharmacotherapy. 2025. doi:10.1093/ehjcvp/pvae059
BibTeX
@article{Weisser2025,
author = {Weisser, Burkhard and Wassmann, Sven and Predel, Hans-Georg and Schmieder, Roland E and Gillessen, Anton and Wilke, Thomas and Blettenberg, Jörg and Randerath, Olaf and Mevius, Antje and Böhm, Michael},
title = {Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2025},
doi = {10.1093/ehjcvp/pvae059}
}
EUVIMED